1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4)
- CAS No.
- 1366126-19-3
- Chemical Name:
- 1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4)
- Synonyms
- DB2115 tertahydrochloride;1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4)
- CBNumber:
- CB210710667
- Molecular Formula:
- C32H31ClN8O2
- Molecular Weight:
- 595.1
- MDL Number:
- MOL File:
- 1366126-19-3.mol
- MSDS File:
- SDS
- TDS File:
- TDS
1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4) price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0311589 | DB2115 tertahydrochloride 98.87% | 1366126-19-3 | 5mg | $379 | 2026-06-04 | Buy |
| ChemScene | CS-0311589 | DB2115 tertahydrochloride 98.87% | 1366126-19-3 | 10mg | $628 | 2026-06-04 | Buy |
| ChemScene | CS-0311589 | DB2115 tertahydrochloride 98.87% | 1366126-19-3 | 25mg | $1192 | 2026-06-04 | Buy |
| ChemScene | CS-0311589 | DB2115 tertahydrochloride 98.87% | 1366126-19-3 | 50mg | $1842 | 2026-06-04 | Buy |
| ChemScene | CS-0311589 | DB2115 tertahydrochloride 98.87% | 1366126-19-3 | 100mg | $2708 | 2026-06-04 | Buy |
1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4) Chemical Properties, Uses, Production
Uses
DB2115 (tertahydrochloride) is a potent inhibitor of myeloid master regulator PU.1. DB2115 (tertahydrochloride) has the potential for researching cancers, including hematologic cancers such as leukemia, as well as other conditions associated with PU. 1 dysfunction (extracted from patent WO2017223260A1, compound DB2115) [1].
Biological Activity
DB2115 (tertahydrochloride) is a potent inhibitor of myeloid master regulator PU.1. DB2115 (tertahydrochloride) has the potential for the treatment of cancers, including hematologic cancers such as leukemia, as well as other conditions associated with PU. 1 dysfunction (extracted from patent WO2017223260A1, compound DB2115) [1].
References
[1]. W. David Wilson, et al. Pu.1 inhibitors. Patent WO2017223260A1.
1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4) Preparation Products And Raw materials
Raw materials
Preparation Products
1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4) Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| BOC Sciences | 16314854226; +8616314854226 | inquiry@bocsci.com | United States | 19852 | 58 |
| TargetMol Chemicals Inc. | 15002134094 | marketing@targetmol.cn | China | 29874 | 58 |
| Guangzhou Ruidi Biotechnology Co., Ltd. | 020-82099279 18988941402 | sales@ubiochem.com | China | 9998 | 58 |
| TargetMol Chemicals Inc. | 13564774135 | marketing@targetmol.com | United States | 19950 | 58 |
| Supplier | Advantage |
|---|---|
| BOC Sciences | 58 |
| TargetMol Chemicals Inc. | 58 |
| Guangzhou Ruidi Biotechnology Co., Ltd. | 58 |
| TargetMol Chemicals Inc. | 58 |
View Latest Price from 1H-Benzimidazole-6-carboximidamide, 2,2'-[1,4-butanediylbis(oxy-4,1-phenylene)]bis-, hydrochloride (1:4) manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-15 | DB2115 tertahydrochloride
1366126-19-3
|
10g | TargetMol Chemicals Inc. |
-

- DB2115 tertahydrochloride
1366126-19-3
- $0.00
- TargetMol Chemicals Inc.




